Search by Drug Name or NDC
NDC 66993-0606-04 Mirtazapine 7.5 mg/1 Details
Mirtazapine 7.5 mg/1
Mirtazapine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Prasco Laboratories. The primary component is MIRTAZAPINE.
MedlinePlus Drug Summary
Mirtazapine is used to treat depression. Mirtazapine is in a class of medications called antidepressants. It works by increasing certain types of activity in the brain to maintain mental balance.
Related Packages: 66993-0606-04Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Mirtazapine
Product Information
NDC | 66993-0606 |
---|---|
Product ID | 66993-606_e1a19354-1c97-49ed-8ec9-bb895dbe69f3 |
Associated GPIs | |
GCN Sequence Number | 054009 |
GCN Sequence Number Description | mirtazapine TABLET 7.5 MG ORAL |
HIC3 | H7B |
HIC3 Description | ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS |
GCN | 21817 |
HICL Sequence Number | 011505 |
HICL Sequence Number Description | MIRTAZAPINE |
Brand/Generic | Generic |
Proprietary Name | Mirtazapine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Mirtazapine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 7.5 |
Active Ingredient Units | mg/1 |
Substance Name | MIRTAZAPINE |
Labeler Name | Prasco Laboratories |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA216751 |
Listing Certified Through | 2024-12-31 |
Package
NDC 66993-0606-04 (66993060604)
NDC Package Code | 66993-606-04 |
---|---|
Billing NDC | 66993060604 |
Package | 500 TABLET, FILM COATED in 1 BOTTLE (66993-606-04) |
Marketing Start Date | 2023-06-01 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.486 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | MIRTAZAPINE 7.5 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis